Improved Quality of Life upon Shifting from Darbepoetin to Luspatercept in Patients with Low-Risk Myelodysplastic Syndrome (MDS)Abdulkareem Mohammed Almomen, Mohammed Eid Dwaima, Hadeel Bashir Akkad, Tarek M. OwaidahBLOOD(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要